Back to User profile » Dr Paul B Savage
Papers published by Dr Paul B Savage:
Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum]
Piktel E, Markiewicz KH, Wilczewska AZ, Daniluk T, Chmielewska S, Niemirowicz-Laskowska K, Mystkowska J, Paprocka P, Savage PB, Bucki R
International Journal of Nanomedicine 2023, 18:659-662
Published Date: 10 February 2023
New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa
Paprocka P, Durnaś B, Mańkowska A, Skłodowski K, Król G, Zakrzewska M, Czarnowski M, Kot P, Fortunka K, Góźdź S, Savage PB, Bucki R
Infection and Drug Resistance 2021, 14:5681-5698
Published Date: 25 December 2021
NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
Chmielewska SJ, Skłodowski K, Piktel E, Suprewicz Ł, Fiedoruk K, Daniluk T, Wolak P, Savage PB, Bucki R
Infection and Drug Resistance 2020, 13:3277-3294
Published Date: 28 September 2020
Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells
Piktel E, Markiewicz KH, Wilczewska AZ, Daniluk T, Chmielewska S, Niemirowicz-Laskowska K, Mystkowska J, Paprocka P, Savage PB, Bucki R
International Journal of Nanomedicine 2020, 15:4573-4589
Published Date: 24 June 2020
Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics
Bucki R, Durnaś B, Wątek M, Piktel E, Cruz K, Wolak P, Savage PB, Janmey PA
Infection and Drug Resistance 2018, 11:77-86
Published Date: 11 January 2018
Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
Li B, Siuta M, Bright V, Koktysh D, Matlock BK, Dumas ME, Zhu M, Holt A, Stec D, Deng S, Savage PB, Joyce S, Pham W
International Journal of Nanomedicine 2016, 11:6103-6121
Published Date: 16 November 2016
Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
Niemirowicz K, Piktel E, Wilczewska AZ, Markiewicz KH, Durnaś B, Wątek M, Puszkarz I, Wróblewska M, Niklińska W, Savage PB, Bucki R
International Journal of Nanomedicine 2016, 11:5443-5455
Published Date: 19 October 2016